APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection

Human Immunology

Volumn 72, Issue 3, 2011, Pages 207-212

  Gourraud, P A ^a   Karaouni, A ^b   Woo, J M ^b   Schmidt, T ^b   Oksenberg, J R ^a   Hecht, F M ^a   Liegler, T J ^a,b   Barbour, J D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

APOBEC3; Haplotype; HIV 1; Innate immunity; Vif

Indexed keywords

GENE PRODUCT; PROTEIN APOBEC3H; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CHROMOSOME 22; DNA SEQUENCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC MARKER; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; VIF GENE; VIRUS GENE; VIRUS INHIBITION;

ADULT; AMINOHYDROLASES; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 22; CYTOSINE DEAMINASE; DNA, VIRAL; FEMALE; GENES, VIF; GENETIC VARIATION; HAPLOTYPES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROVIRUSES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79651473962     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.12.008     Document Type: Article

References (25)

1. Zhen A., Wang T., Zhao K., Xiong Y., Yu X.F. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. J Virol 2010, 84:1902-1911.
2. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003, 9:1404-1407.
3. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
4. Henriet S., Mercenne G., Bernacchi S., Paillart J.C., Marquet R. Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol Mol Biol Rev 2009, 73:211-232.
5. Yu Q., Konig R., Pillai S., Chiles K., Kearney M., Palmer S., et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 2004, 11:435-442.
6. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 2004, 78:6073-6076.
7. Pillai S.K., Wong J.K., Barbour J.D. Turning up the volume on mutational pressure: is more of a good thing always better?. (A case study of HIV-1 Vif and APOBEC3). Retrovirology 2008, 5:26-34.
8. OhAinle M., Kerns J.A., Malik H.S., Emerman M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J Virol 2006, 80:3853-3862.
9. Bourara K., Liegler T.J., Grant R.M. Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1. PLoS Pathog 2007, 3:1477-1485.
10. Harari A., Ooms M., Mulder L.C., Simon V. Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H. J Virol 2009, 83:295-303.
11. OhAinle M., Kerns J.A., Li M.M., Malik H.S., Emerman M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 2008, 4:249-259.
12. Armitage A.E., Katzourakis A., de Oliveira T., Welch J.J., Belshaw R., Bishop K.N., et al. Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus herv-K(HML2) sequences. J Virol 2008, 82:8743-8761.
13. Kijak G.H., Janini L.M., Tovanabutra S., Sanders-Buell E., Arroyo M.A., Robb M.L., et al. Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. Virology 2008, 376:101-111.
14. Reddy K., Winkler C.A., Werner L., Mlisana K., Abdool Karim S.S., Ndung'U T. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load. AIDS 2010, 24:195-204.
15. Barbour J.D., Hecht F.M., Wrin T., Segal M.R., Ramstead C.A., Liegler T.J., et al. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection. J Infect Dis 2004, 190:251-256.
16. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
17. Gourraud P.A., Feolo M. The Babel Tower revisited: SNPs-Indels-CNVs. Confusion in naming sequence variant always rises from ashes. Tissue Antigens 2010, 75:199-200.
18. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
19. Barrett J.C. Haploview: Visualization and analysis of SNP genotype data. CSH Protoc 2009, 10. pdb.ip71.
20. Gourraud P.A., Genin E., Cambon-Thomsen A. Handling missing values in population data: consequences for maximum likelihood estimation of haplotype frequencies. Eur J Hum Genet 2004, 12:805-812.
21. Yu Z., Schaid D.J. Methods to impute missing genotypes for population data. Hum Genet 2007, 122:495-504.
22. Kothe D., Byers R.H., Caudill S.P., Satten G.A., Janssen R.S., Hannon W.H., Mei J.V. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003, 33:625-634.
23. Barbour J.D., Hecht F.M., Wrin T., Liegler T.J., Ramstead C.A., Busch M.P., et al. Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS 2004, 18:1683-1689.
24. Mulder L.C., Harari A., Simon V. Cytidine deamination induced HIV-1 drug resistance. Proc Natl Acad Sci U S A 2008, 105:5501-5506.
25. Li M.M., Wu L.I., Emerman M. The range of human APOBEC3H sensitivity to lentiviral Vif proteins. J Virol 2010, 84:88-95.